BPG is committed to discovery and dissemination of knowledge
Case Report
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Clin Pediatr. Sep 9, 2026; 15(3): 120925
Published online Sep 9, 2026. doi: 10.5409/wjcp.120925
Recurrent acute liver failure in infancy - a novel SCYL1 mutation: A case report
Doaa Zourob, Amal Al Teneiji, Mohammad Miqdady, Eman Al Atrash
Doaa Zourob, Department of Pediatrics, Division of Pediatric Gastroenterology, Al Mushrif Children’s Specialty Center, AHS, Pure Health Group, Abu Dhabi 971, United Arab Emirates
Amal Al Teneiji, Department of Pediatrics, Division of Genetics and Metabolic Medicine, Sheikh Khalifa Medical City, Abu Dhabi 971, United Arab Emirates
Mohammad Miqdady, Department of Pediatrics, Division of Pediatric Gastroenterology, Sheikh Khalifa Medical City, Abu Dhabi 971, United Arab Emirates
Eman Al Atrash, Department of Pediatrics, Division of Pediatric Gastroenterology, Mediclinic Airport Road Hospital, Abu Dhabi 971, United Arab Emirates
Author contributions: Zuroub D drafted the manuscript; Al Atrash E edited the manuscript, Zuroub D, Al Atrash E, Teneiji AA, and Miqdady M read and approved the final version of the manuscript.
AI contribution statement: Grammarly was used for language polishing and for response to the reviewer’s comments. AI was not used for writing the manuscript.
Informed consent statement: Informed written consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Corresponding author: Eman Al Atrash, MD, Consultant, Department of Pediatrics, Division of Gastroenterology, Mediclinic Airport Road Hospital, Airport Road, Abu Dhabi 971, United Arab Emirates. emanalatrash8@gmail.com
Received: March 13, 2026
Revised: April 16, 2026
Accepted: May 25, 2026
Published online: September 9, 2026
Processing time: 142 Days and 14 Hours
Abstract
BACKGROUND

Recurrent acute liver failure (ALF) in children is rare and diagnostically challenging. Despite rigorous investigations, a significant proportion of patients remain without a definitive diagnosis. Recently across the literature, biallelic pathogenic variants in the SCYL1 gene had been identified to cause a hepatocerebellar syndrome characterized by low gamma-glutamyl transferase (GGT) cholestasis, episodic ALF, and progressive neurodegeneration, collectively termed cholestasis, ALF, and neurodegeneration (CALFAN) syndrome (or spinocerebellar ataxia, autosomal recessive type 21). A high index of suspicion is paramount to recognizing this entity early, given that its presentation overlaps with more prevalent conditions, and delayed diagnosis carries significant morbidity and mortality risk.

CASE SUMMARY

We report a 19-month-old girl of Middle Eastern ethnicity, presenting with recurrent episodes of febrile illness, ALF, and low-GGT cholestasis initially misattributed to viral hepatitis. Clinical evaluation revealed subtle neurological abnormalities, including tremors and fine motor delay. The highlight of her presentation was pancytopenia, which expanded the known phenotypic spectrum. Extensive metabolic, infectious, and autoimmune investigations were inconclusive. Whole exome sequencing identified a homozygous likely pathogenic SCYL1 variant (c.1420C>T; p.Arg474*), consistent with CALFAN syndrome/spinocerebellar ataxia, autosomal recessive type 21. Liver biopsy showed degenerative and early fibrotic changes. Liver function partially improved with corticosteroids and supportive care but did not normalize; a third episode of liver failure occurred at 22 months in the setting of a febrile urinary tract infection.

CONCLUSION

SCYL1-related disease should be considered in children with unexplained recurrent ALF, particularly when low-GGT cholestasis and neurological features co-exist. Early genetic evaluation using whole exome sequencing is essential for establishing the diagnosis. Steroid therapy was transiently associated with partial biochemical improvement, although its mechanism in a genetic disorder remains uncertain. This case further demonstrates that pancytopenia may be part of the CALFAN phenotypic spectrum.

Keywords: SCYL1 mutation; Recurrent acute liver failure; Pediatric acute liver failure; Cholestasis, acute liver failure, and neurodegeneration syndrome; Spinocerebellar ataxia, autosomal recessive type 21; Hepatocerebellar syndrome; Neurodegeneration

Core Tip: Recurrent acute liver failure (RALF) in children is an uncommon but life- threatening condition that may mask underlying genetic disorders. We report a child with febrile RALF and subtle neurological findings in whom whole exome sequencing identified a homozygous SCYL1 mutation consistent with a hepatocerebellar syndrome. This case highlights the importance of early genetic evaluation in unexplained RALF, particularly when neurological features are present. Prompt recognition of SCYL1- related disease can refine diagnosis, guide management, prevent unnecessary investigations, and improve long-term clinical outcomes.

Write to the Help Desk